Literature DB >> 3013032

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

P P Roy-Byrne, T W Uhde, R M Post, W Gallucci, G P Chrousos, P W Gold.   

Abstract

Eight patients with panic disorder had significantly lower ACTH and cortisol responses to corticotropin-releasing hormone and a significantly lower ratio of ACTH to cortisol response than 30 normal control subjects. These responses resemble those previously reported for depressed patients except that they occurred in the face of significantly elevated basal cortisol and ACTH levels. These results suggest that patients with panic disorder have an element of chronic hypercortisolemia, like depressed patients, but also a more acute perturbation in ACTH secretion, not previously seen in depressed patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013032     DOI: 10.1176/ajp.143.7.896

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

2.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  An integrated map of corticotropin-releasing hormone signaling pathway.

Authors:  Tejaswini Subbannayya; Lavanya Balakrishnan; Granthali Sudarshan; Jayshree Advani; Santosh Kumar; Riaz Mahmood; Bipin Nair; Ravi Sirdeshmukh; Kanchan K Mukherjee; Sudhir N Umathe; Rajesh Raju; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2013-03-16       Impact factor: 5.782

Review 4.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 5.  Development of CRF1 receptor antagonists as antidepressants and anxiolytics: progress to date.

Authors:  Glenn R Valdez
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Behavior and metabolic disease.

Authors:  P Björntorp
Journal:  Int J Behav Med       Date:  1996

7.  Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system.

Authors:  K R Melia; R S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating.

Authors:  Christiaan H Vinkers; Victoria B Risbrough; Mark A Geyer; Sorana Caldwell; Malcolm J Low; Richard L Hauger
Journal:  Pharmacol Biochem Behav       Date:  2007-01-31       Impact factor: 3.533

Review 9.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

10.  Pregnant women's cortisol is elevated with anxiety and depression - but only when comorbid.

Authors:  Lynn M Evans; Michael M Myers; Catherine Monk
Journal:  Arch Womens Ment Health       Date:  2008-05-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.